Recent evidence suggests that chronic exposure to lactobacilli, which are p
art of the normal intestinal flora, inhibits the development of allergic di
sorders. Allergy is mediated by Th2 cells, which produce high levels of IL4
and IL5, and suppressive effects of lactic acid bacteria on the developmen
t of allergy have been attributed to their Th1-inducing properties. On the
other hand, lactic acid bacteria have also been shown to suppress autoimmun
e disorders which are mediated by Th1 cells producing high levels of IFN ga
mma. To study this apparent discrepancy, the immunomodulatory potential of
lactobacilli was evaluated using recombinants that express an immunodominan
t T-cell epitope of Der p 1 of house dust mites. Mucosal immunization of C5
7BL/6 J mice with such recombinants resulted in the induction of T cells wh
ich produced low amounts of IFN gamma. Immunization with the house dust mit
e peptide followed by treatment with recombinant Lactobacillus plantarum re
sulted in the inhibition of both IFN gamma and IL5 production. The effect o
n IFN gamma production was shown to be a non-specific effect of L. plantaru
m. The effect on IL5 production, however, was only observed when the recomb
inant expressing the Der p 1 peptide, but not the control recombinant, was
used for treatment. Neither of the recombinants had an effect on the antibo
dy response. Taken together, these data suggest that recombinant L. plantar
um may be a suitable candidate for the treatment of allergic disorders.